Without policy intervention to address average sales price-based challenges to biosimilar market sustainability, there is a ...
The Centers for Medicare & Medicaid Services (CMS) recently issued several important updates concerning the reporting of Average Sales Price (ASP) with potential implications for manufacturers. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback